VIR · CIK 0001706431 · operating
Vir Biotechnology, Inc. (VIR) is a biological products, (no diagnostic substances) company incorporated in DE, listed on the Nasdaq. With a market capitalization of $1.3 billion, Vir Biotechnology, Inc. is a small-cap company. The stock currently trades at $9.34, up 2.75% today, with a 52-week range of $4.16–$10.94.
Fiscal years are as reported by the company and may not align with the calendar year. For example, Apple's FY 2024 ends in September 2024.
| Fiscal Year | EPS Diluted | EPS Basic | YoY | |
|---|---|---|---|---|
| 2025 | $-3.16 | $-3.16 | +17.5% | |
| 2024 | $-3.83 | $-3.83 | +16.6% | |
| 2023 | $-4.59 | $-4.59 | -219.8% | |
| 2022 | $3.83 | $3.89 | -3.3% | |
| 2021 | $3.96 | $4.07 | +577.1% | |
| 2020 | $-0.83 | $-0.83 | -16.9% | |
| 2019 | $-0.71 | $-0.69 | — |
| Report Date | Filed | Accession Number | |
|---|---|---|---|
| 2025-12-31 | 2026-02-23 | 0001628280-26-010749 | SEC ↗ |
| 2024-12-31 | 2025-02-27 | 0001628280-25-008245 | SEC ↗ |
| 2023-12-31 | 2024-02-26 | 0001628280-24-006852 | SEC ↗ |
| 2022-12-31 | 2023-02-28 | 0000950170-23-005118 | SEC ↗ |
| 2021-12-31 | 2022-02-28 | 0000950170-22-002295 | SEC ↗ |
| 2020-12-31 | 2021-02-25 | 0001564590-21-008915 | SEC ↗ |
| 2019-12-31 | 2020-03-26 | 0001564590-20-013194 | SEC ↗ |